inSomaBio
Durham
About inSomaBio
InSoma Bio integrates biology and materials science to solve problems in tissue engineering and regenerative medicine. It offers genetically engineer protein-based materials that can mimic the naturally found elastin found in extracellular tissues. The company also offers reconstructive plastic surgeries and injectable materials.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $8.0M
- Funding stage: Seed
- Last round: Seed (Oct 2025)
- Website: insomabio.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/insomabio-113407 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.